Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients

Ellison, George T. H., Kaufman, Jay S., Head, Rosemary F., Martin, Paul A. and Kahn, Jonathan D. (2008) Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients. The Journal of Law Medicine & Ethics, 36(3), pp. 449-457. ISSN (print) 1073-1105

Actions (Repository Editors)

Item Control Page Item Control Page